TSS
PTX

Two Sigma Securities’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Two Sigma Securities’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,192
Closed -$11K – 3149
2018
Q3 		$11K Buy
+11,192
New +$18.7K ﹤0.01% 2496
2016
Q2 		– Sell
-1,258
Closed -$13K – 587
2016
Q1 		$13K Buy
+1,258
New +$25K 0.02% 254

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MFGP
Marshall Financial Group (Pennsylvania) Doylestown, Pennsylvania $364M AUM 12.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Securities's PTX Position: Q4 2018 in Review

Two Sigma Securities sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2018, closing a stake of 11,192 shares — an estimated $11K sold.

Two Sigma Securities first reported a position in PTX in Q1 2016 and held it in 2 quarters. The position peaked at $13K in Q1 2016. 32 funds tracked by Wall St. Rank hold PTX as of Q4 2018.

  • Two Sigma Securities reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
  • Two Sigma Securities sold 11,192 Pernix Therapeutics Holdings, Inc. shares in Q4 2018, an estimated $11K.
  • Two Sigma Securities first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2016 and held it in 2 quarters.
  • Two Sigma Securities's Pernix Therapeutics Holdings, Inc. position peaked at $13K in Q1 2016.
  • 32 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2018.

Based on Two Sigma Securities's 13F filing for Q4 2018, filed 14 Feb 2019.